Summary
- Current Price
- As of today, ATNM price is $1.05, down -2.78% on
- Current Price All-Time High
- ATNM price is currently -99.77% below its historical high of $450.00 set on
- Market Cap
- ATNM current market cap is $33M, down -43.85% year-over-year
- PE Ratio
- ATNM PE ratio is unknown
- Revenue
- ATNM current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for ATNM has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Actinium Pharmaceuticals, Inc. |
| Ticker | NYSEAmerican: ATNM |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | actiniumpharma.com |
| Employees | 31 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.05 | ||
| Price, 1D Change | -2.78% | |
| $33M | ||
| - | ||
| - | ||
| 1.17 | ||
| $0 | ||
| Revenue, 1Y Change | -100.00% | |
| -$1.27 | ||
| EPS, 1Y Change | +30.69% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.27 | ||
| EPS Estimate | N/A | -$1.08 |
| EPS Est. Change | N/A | +15.08% |
| $0.00 | ||
| Revenue Estimate | N/A | $92.50K |
| Revenue Est. Change | N/A | - |
| $1.05 | ||
| Price Target | - | $5.00 |
| Price Tgt. Change | - | +376.19% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.05 | -$1.84 | +10.49% | |
| -$1.43 | -$1.27 | +10.75% | |
| -$1.08 | N/A | +15.08% | |
| -$0.79 | N/A | +37.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $81.00K | $81.00K | 0.00% | |
| - | $0.00 | - | |
| $92.50K | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -43.85% | ||
| -88.76% | ||
| -43.85% | ||
| -86.34% | ||
| -100.00% | ||
| -100.00% | ||
| +30.69% | ||
| -5.59% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.05 | ||
| $1.44 | ||
| SMA 200 vs Price | +37.59% | |
| $1.17 | ||
| SMA 50 vs Price | +11.17% | |
| 1.17 | ||
| $0.07 | ||
| 40.26 | ||
| 45.49% | ||
| 69.86% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.27 | ||
| -$811.00K | ||
| - | ||
| -$42.12M | ||
| - | ||
| -$38.24M | ||
| - | ||
| -$41.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.05 | ||
| 9.14 | ||
| 9.14 | ||
| - | ||
| - | ||
| -7.17 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 363.95 | ||
| 2.38 | ||
| 0.53 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $32.76M | ||
| $72.90M | ||
| $76.90M | ||
| $74.51M | ||
| $44.14M | ||
| $8.15M | ||
| $1.57M | ||
| $580.00K | ||
| $7.57M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $42.12M | ||
| $42.12M | ||
| $811.00K | ||
| $12.08M | ||
| $811.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$33.07M | ||
| -$11.00K | ||
| $29.32M | ||
| $11.00K | ||
| -$33.08M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Stephens & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ATNM
FAQ
What is the ticker symbol for Actinium Pharmaceuticals, Inc.?
The ticker symbol for Actinium Pharmaceuticals, Inc. is NYSEAmerican:ATNM
Does Actinium Pharmaceuticals, Inc. pay dividends?
No, Actinium Pharmaceuticals, Inc. does not pay dividends
What sector is Actinium Pharmaceuticals, Inc. in?
Actinium Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Actinium Pharmaceuticals, Inc. in?
Actinium Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Actinium Pharmaceuticals, Inc. based in?
Actinium Pharmaceuticals, Inc. is headquartered in United States
When did Actinium Pharmaceuticals, Inc. go public?
Actinium Pharmaceuticals, Inc. initial public offering (IPO) was on December 27, 2012
Is Actinium Pharmaceuticals, Inc. in the S&P 500?
No, Actinium Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Actinium Pharmaceuticals, Inc. in the NASDAQ 100?
No, Actinium Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Actinium Pharmaceuticals, Inc. in the Dow Jones?
No, Actinium Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Actinium Pharmaceuticals, Inc. last earnings report?
Actinium Pharmaceuticals, Inc.'s most recent earnings report was on May 15, 2025
When does Actinium Pharmaceuticals, Inc. report earnings?
The date for Actinium Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ATNM Official Website www.actiniumpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1388320/000121390025026371/0001213900-25-026371-index.htm
- ATNM Profile on Yahoo Finance finance.yahoo.com/quote/ATNM
- ATNM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atnm